GO:0006600 creatine metabolic process: Energy Shuttle, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006600 creatine metabolic process describes the chemical reactions and pathways involving creatine, a compound synthesized from arginine, glycine, and methionine that is critical for cellular energy buffering.
• Creatine metabolism is a three-dimensional network linking intracellular energy shuttling to systemic metabolic regulation, with roles in muscle, brain, immune cells, and cancer.
• The creatine kinase/phosphocreatine system rapidly regenerates ATP during high-energy demand, and its dysfunction is implicated in metabolic, neuromuscular, and neoplastic diseases.
• Key genes include GATM, GAMT, CKB, CKM, SLC6A8, and CKMT1/2, which mediate synthesis, transport, and reversible phosphorylation of creatine.
• Creatine metabolism influences tumor progression; hypoxia-induced creatine uptake can reprogram metabolism and antagonize PARP1-mediated cell death in hepatocellular carcinoma.
• Creatine supplementation has broad health implications beyond athletics, including women's health across the lifespan and clinical populations.
Description
Creatine (N-(aminoiminomethyl)-N-methylglycine) is a nitrogenous organic acid that plays a central role in cellular energy homeostasis. The Gene Ontology term GO:0006600, creatine metabolic process, encompasses the chemical reactions and pathways involving creatine, including its biosynthesis from arginine, glycine, and methionine, its transport, and its reversible phosphorylation to phosphocreatine. This process is essential for maintaining ATP levels in tissues with high and fluctuating energy demands, such as skeletal muscle, heart, and brain. Researchers study creatine metabolism to understand not only exercise performance but also fundamental aspects of energy shuttling, immune function, and cancer biology. The creatine kinase/phosphocreatine circuit acts as a spatial and temporal energy buffer, transferring high-energy phosphates from sites of production to sites of consumption. Beyond its classical role, creatine metabolism has emerged as a systemic metabolic regulator with implications for diseases ranging from creatine deficiency syndromes to hepatocellular carcinoma. The availability of creatine from endogenous synthesis and dietary intake, along with its transport across membranes, makes this pathway a target for nutritional and pharmacological interventions. This article provides a research-grade overview of GO:0006600, integrating authoritative GO definitions with published literature to support experimental design and therapeutic exploration.
creatine metabolic process At A Glance
| GO ID | GO:0006600 |
|---|---|
| GO term | creatine metabolic process |
| Ontology | biological_process |
| Synonym | creatine metabolism |
| Definition | The chemical reactions and pathways involving creatine (N-(aminoiminomethyl)-N-methylglycine), a compound synthesized from the amino acids arginine, glycine, and methionine that occurs in muscle. |
| Major function | Energy homeostasis via the creatine kinase/phosphocreatine system; biosynthesis and transport of creatine. |
| Key tissues | Skeletal muscle, heart, brain, kidney, liver, and immune cells. |
| Related pathways | Arginine and proline metabolism, glycine, serine and threonine metabolism, and ATP synthesis. |
What Is GO:0006600?
According to the Gene Ontology, GO:0006600 creatine metabolic process is defined as the chemical reactions and pathways involving creatine (N-(aminoiminomethyl)-N-methylglycine), a compound synthesized from the amino acids arginine, glycine, and methionine that occurs in muscle. This biological process includes the biosynthesis of creatine, its phosphorylation to phosphocreatine, and its degradation, as well as the transport and utilization of creatine within cells. The term is synonymous with creatine metabolism and is classified under biological_process.
Why Is creatine metabolic process Important in Cell Biology?
Creatine metabolic process is fundamentally important because it maintains cellular energy balance, particularly in tissues with high ATP turnover such as muscle and brain. The creatine kinase system provides a rapid temporal and spatial energy buffer, and its dysfunction is linked to metabolic myopathies, neurodegenerative conditions, and cancer progression. Moreover, creatine metabolism intersects with immunity and systemic metabolic regulation, making it a hub for understanding health and disease.
• Maintains ATP homeostasis in skeletal muscle, heart, and brain through the phosphocreatine shuttle.
• Supports normal neurological function; creatine deficiency syndromes cause intellectual disability and seizures.
• Modulates immune cell function and inflammatory responses.
• Plays a role in cancer metabolism, where creatine uptake can promote tumor progression and therapy resistance.
• Influences systemic energy balance and metabolic regulation across tissues.
• Provides a target for nutritional supplementation with benefits for women's health and clinical populations.
• Serves as a biomarker and therapeutic target in metabolic and neuromuscular disorders.
• Enables experimental dissection of energy shuttling using genetic models and metabolic tracers.
What Happens During creatine metabolic process?
Biosynthesis of creatine
In simple terms: The body builds creatine from three amino acids in two main steps.
Creatine is synthesized endogenously from arginine, glycine, and methionine. The first and rate-limiting step occurs in the kidney, where L-arginine:glycine amidinotransferase (GATM) transfers an amidino group from arginine to glycine, forming guanidinoacetate and ornithine. Guanidinoacetate is then methylated in the liver by guanidinoacetate N-methyltransferase (GAMT) using S-adenosylmethionine as the methyl donor to produce creatine. This pathway is tightly regulated by hormonal and nutritional factors, and its disruption leads to creatine deficiency syndromes.
Transport and uptake
In simple terms: Creatine must be moved into cells by specific transporter proteins.
Creatine is transported across cell membranes by the sodium- and chloride-dependent creatine transporter SLC6A8 (CT1). This transporter is expressed in many tissues, including skeletal muscle, brain, and kidney, and is essential for cellular creatine uptake. Defects in SLC6A8 cause creatine transporter deficiency, an X-linked disorder characterized by intellectual disability and speech delay. Additionally, creatine can be taken up from the diet via intestinal absorption, and its distribution among tissues relies on the coordinated action of transporters and biosynthesis.
Phosphorylation and energy buffering
In simple terms: Creatine stores energy as phosphocreatine, which can quickly regenerate ATP.
In the cytosol and mitochondria, creatine kinases (CKB, CKM, and mitochondrial CKMT1/2) catalyze the reversible transfer of a phosphoryl group from ATP to creatine, yielding phosphocreatine and ADP. This reaction is central to the creatine/phosphocreatine energy shuttle, which buffers ATP levels during periods of high energy demand and facilitates the transfer of high-energy phosphates from mitochondria to sites of ATP consumption. The mitochondrial creatine kinases (CKMT1 and CKMT2) are located in the intermembrane space and couple to oxidative phosphorylation, while cytosolic isoforms (CKB and CKM) are associated with ATP-consuming processes such as muscle contraction.
Degradation and excretion
In simple terms: Creatine breaks down into creatinine, which is removed by the kidneys.
Creatine and phosphocreatine spontaneously cyclize to form creatinine at a relatively constant rate. Creatinine is then filtered by the kidneys and excreted in urine. This degradation pathway is clinically important because serum creatinine is a widely used marker of renal function. The balance between creatine synthesis, intake, and degradation determines whole-body creatine stores, which can be influenced by dietary supplementation.
Systemic metabolic regulation
In simple terms: Creatine metabolism communicates with other organs to regulate whole-body energy.
Recent evidence indicates that creatine metabolism forms a three-dimensional network that extends beyond intracellular energy shuttling to act as a systemic metabolic regulatory switch. Creatine and its intermediates can influence gene expression, insulin sensitivity, and immune responses, and they participate in inter-organ communication via the bloodstream. This systemic role highlights the importance of creatine metabolism in integrating energy status across tissues and in conditions such as obesity, diabetes, and cancer.
Key Genes Involved in GO:0006600 creatine metabolic process
The following genes and proteins are central to creatine metabolic process, mediating its biosynthesis, transport, phosphorylation, and degradation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GATM | L-arginine:glycine amidinotransferase; catalyzes the first step of creatine biosynthesis | Mutations cause creatine deficiency syndrome; target for metabolic studies |
| GAMT | Guanidinoacetate N-methyltransferase; catalyzes the second step of creatine biosynthesis | Defects lead to guanidinoacetate methyltransferase deficiency; model for neurometabolic disorders |
| SLC6A8 | Creatine transporter; mediates sodium- and chloride-dependent creatine uptake | Mutations cause X-linked creatine transporter deficiency; studied in brain and muscle |
| CKB | Cytosolic creatine kinase B; reversibly phosphorylates creatine to phosphocreatine | Important for brain and smooth muscle energy homeostasis; implicated in cancer |
| CKM | Cytosolic creatine kinase M; muscle-specific isoform | Key for skeletal and cardiac muscle energy buffering; biomarker of muscle damage |
| CKMT1A | Mitochondrial creatine kinase 1A; couples to oxidative phosphorylation | Expressed in brain and other tissues; involved in mitochondrial energy transfer |
| CKMT1B | Mitochondrial creatine kinase 1B; isoform of CKMT1 | Similar role to CKMT1A; potential redundancy in energy shuttling |
| CKMT2 | Mitochondrial creatine kinase 2; sarcomeric mitochondrial isoform | Critical for cardiac and skeletal muscle energy metabolism |
| SLC6A8 | Creatine transporter (CT1) | Target for creatine uptake studies and cancer metabolism |
| ARG1 | Arginase 1; provides arginine for creatine synthesis | Links urea cycle to creatine metabolism; relevant in liver and immune cells |
| GLYC | Glycine cleavage system; supplies glycine | Contributes to one-carbon metabolism and creatine synthesis |
| MAT1A | Methionine adenosyltransferase; produces S-adenosylmethionine for GAMT | Regulates methyl supply for creatine synthesis |
| CBS | Cystathionine beta-synthase; transsulfuration affects methionine cycle | Indirectly influences creatine synthesis via homocysteine metabolism |
| MTHFR | Methylenetetrahydrofolate reductase; affects methyl donor availability | Polymorphisms may influence creatine synthesis efficiency |
| SLC6A8 | Creatine transporter | Studied in creatine transporter deficiency and cancer |
| ATP5A1 | Mitochondrial ATP synthase subunit; interacts with creatine kinases | Links creatine metabolism to oxidative phosphorylation |
| VDAC1 | Voltage-dependent anion channel; facilitates mitochondrial creatine kinase coupling | Important for mitochondrial energy shuttle |
| ANT1 | Adenine nucleotide translocator; exchanges ATP/ADP across inner mitochondrial membrane | Works with creatine kinases in energy transfer |
How Is creatine metabolic process Regulated?
Creatine metabolic process is regulated at multiple levels. The expression and activity of GATM and GAMT are influenced by hormonal signals (e.g., growth hormone, thyroid hormone, testosterone) and nutritional status, including dietary creatine and protein intake. The creatine transporter SLC6A8 is regulated by substrate availability and cellular energy demand, and its trafficking can be modulated by signaling pathways such as AMPK and mTOR. Creatine kinase isoforms are regulated transcriptionally and post-translationally, with phosphorylation and subcellular localization affecting their function in energy shuttling. Additionally, systemic factors such as insulin and exercise can alter creatine uptake and storage in muscle. At the systemic level, creatine metabolism is integrated with one-carbon metabolism and arginine availability, which are themselves regulated by diet and genetic variation.
creatine metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GATM | Creatine deficiency syndrome (arginine:glycine amidinotransferase deficiency) | KO mouse, patient-derived iPSCs, point-mutation knock-in |
| GAMT | Guanidinoacetate methyltransferase deficiency | KO mouse, knock-in of patient mutations, overexpression |
| SLC6A8 | Creatine transporter deficiency (X-linked intellectual disability) | KO mouse, patient fibroblasts, transporter assays |
| CKB | Cancer progression, brain energy metabolism | KO and overexpression in cancer cell lines, xenografts |
| CKM | Muscle energy homeostasis, myopathies | KO mouse, muscle-specific overexpression, exercise models |
Creatine deficiency syndromes
Inborn errors of creatine metabolism, including GATM, GAMT, and SLC6A8 deficiencies, lead to cerebral creatine deficiency syndromes characterized by intellectual disability, speech delay, seizures, and behavioral abnormalities. These disorders highlight the critical role of creatine in brain function and energy homeostasis. Diagnosis relies on magnetic resonance spectroscopy and genetic testing, and treatment strategies include creatine supplementation and dietary manipulation, though transporter defects respond poorly.
Cancer metabolism
Creatine metabolism is reprogrammed in several cancers. In hepatocellular carcinoma, hypoxia-induced creatine uptake via SLC6A8 reprograms metabolism to antagonize PARP1-mediated cell death and facilitate tumor progression. Creatine kinases, particularly CKB, are also implicated in cancer cell survival and metastasis, making the creatine pathway a potential therapeutic target. These findings underscore the importance of creatine metabolism in oncology and the need for further research into isoform-specific roles.
Metabolic and neuromuscular disorders
Alterations in creatine metabolism have been observed in metabolic myopathies, insulin resistance, and aging-related muscle loss. Creatine supplementation has been studied for its benefits in muscle function, cognitive health, and clinical populations, including women across the lifespan. The creatine kinase system is also a biomarker of muscle damage and cardiac injury, reflecting its clinical relevance.
Immune function and inflammation
Creatine metabolism influences immune cell function by supporting energy demands during activation and proliferation. Macrophages and T cells rely on the creatine/phosphocreatine system for ATP buffering, and creatine availability can modulate inflammatory responses. This connection has implications for autoimmune diseases and immunotherapy.
From creatine metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GATM affect creatine synthesis and brain function? | GATM knockout mouse or human iPSC-derived neurons |
| How do patient mutations in SLC6A8 affect transporter function? | Point-mutation knock-in in cell lines or patient-derived cells |
| Can overexpression of CKB promote cancer cell survival under hypoxia? | CKB overexpression in hepatocellular carcinoma cell lines and xenografts |
| What is the role of mitochondrial CKMT2 in cardiac energy shuttling? | CKMT2 knockout mouse and cardiomyocyte-specific knock-in |
| Does creatine supplementation rescue metabolic defects in GAMT deficiency? | GAMT KO mouse treated with creatine and arginine restriction |
| How does creatine metabolism influence immune cell activation? | Conditional knockout of creatine transporters in immune cells |
How to Study the creatine metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Stable isotope tracing + LC-MS | Flux through creatine synthesis and degradation | Quantifying creatine biosynthesis in cells and animal models |
| RNA-seq / scRNA-seq | Expression of creatine metabolism genes | Tissue-specific and single-cell profiling |
| CRISPR knockout screens | Genes required for creatine metabolism or sensitivity | Identifying novel regulators and therapeutic targets |
| Phosphoproteomics | Phosphorylation of creatine kinases and regulators | Mapping signaling pathways that control creatine metabolism |
| Magnetic resonance spectroscopy | Creatine and phosphocreatine levels in vivo | Diagnosis of creatine deficiency and monitoring therapy |
| ATP/phosphocreatine biosensors | Real-time energy dynamics | Live-cell imaging of energy shuttling |
| Creatine uptake assay | Transport activity of SLC6A8 | Screening for transporter modulators |
| Immunoblotting / ELISA | Protein levels of GATM, GAMT, CKB, etc. | Validation of expression changes in disease models |
Metabolic flux analysis
Stable isotope tracing with 13C- or 15N-labeled precursors (e.g., arginine, glycine, methionine) coupled to mass spectrometry can quantify creatine synthesis and turnover in cells and tissues. This approach reveals pathway activity and identifies metabolic bottlenecks.
Genomic and transcriptomic profiling
RNA-seq and single-cell RNA-seq can measure expression of creatine metabolism genes (GATM, GAMT, SLC6A8, CKB, CKM, CKMT1/2) across tissues and conditions. CRISPR screens combined with transcriptomics can identify regulators of these genes.
Proteomics and post-translational modification analysis
Mass spectrometry-based proteomics can quantify creatine kinase isoforms and their post-translational modifications, such as phosphorylation, which regulate enzyme activity and localization. Proximity labeling can map interactors of the creatine kinase complex.
Imaging and functional assays
Magnetic resonance spectroscopy (MRS) allows non-invasive measurement of creatine and phosphocreatine levels in vivo. Fluorescent biosensors for ATP and phosphocreatine can monitor real-time energy dynamics in live cells. Creatine uptake assays using radiolabeled creatine or fluorescent analogs assess transporter activity.
How CRISPR Can Be Used to Study GO:0006600 creatine metabolic process
Knockout
CRISPR-Cas9 knockout of creatine metabolism genes (e.g., GATM, GAMT, SLC6A8, CKB, CKM) enables loss-of-function studies to determine their roles in energy homeostasis, cell proliferation, and disease. For example, GATM knockout cells cannot synthesize creatine and require exogenous creatine for growth, providing a model for creatine auxotrophy. Knockout of SLC6A8 abolishes creatine uptake, mimicking transporter deficiency.
Point Mutation
Point mutations identified in patients with creatine deficiency syndromes can be introduced into cell lines or animal models using CRISPR base editing or homology-directed repair. These models help dissect the functional impact of specific missense or nonsense mutations on enzyme activity, protein stability, and transporter function.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins at endogenous loci allows tracking of creatine metabolism proteins in live cells and tissues. Knock-in of disease-associated mutations or reporter cassettes (e.g., luciferase) facilitates drug screening and mechanistic studies.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of creatine metabolism genes (e.g., CKB, SLC6A8) can model gain-of-function states observed in cancer and other diseases. Overexpression of CKB in hepatocellular carcinoma cells promotes survival under hypoxia, and SLC6A8 overexpression enhances creatine uptake and tumor growth.
How EDITGENE Supports creatine metabolic process Research
Researchers studying creatine metabolic process-related genes often need to determine whether a candidate gene is causally involved in energy homeostasis, disease progression, or therapeutic response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of genes such as GATM, GAMT, SLC6A8, CKB, and CKMT2.
Contact EDITGENE today to design your custom CRISPR model for creatine metabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| GAMT Knockout HEK293 Cell Line | EDJ-KQ4676 | Human | 2593 | Details Get a Quote |
| GATM Knockout HEK293 Cell Line | EDJ-KQ4684 | Human | 2628 | Details Get a Quote |
| SLC6A8 Knockout HEK293 Cell Line | EDJ-KQ5775 | Human | 6535 | Details Get a Quote |
| GATM Knockout A-549 Cell Line | EDJ-KQ26145 | Human | 2628 | Details Get a Quote |
| SLC6A8 Knockout HeLa Cell Line | EDJ-KQ27935 | Human | 6535 | Details Get a Quote |
| SLC6A8 Knockout A-549 Cell Line | EDJ-KQ29192 | Human | 6535 | Details Get a Quote |
| SLC6A8 Knockout HCT 116 Cell Line | EDJ-KQ29193 | Human | 6535 | Details Get a Quote |
| GAMT Knockout A-549 Cell Line | EDJ-KQ27370 | Human | 2593 | Details Get a Quote |
| GAMT Knockout HCT 116 Cell Line | EDJ-KQ27371 | Human | 2593 | Details Get a Quote |
| GAMT Knockout HeLa Cell Line | EDJ-KQ27372 | Human | 2593 | Details Get a Quote |
| GATM Knockout HCT 116 Cell Line | EDJ-KQ27388 | Human | 2628 | Details Get a Quote |
| GATM Knockout HeLa Cell Line | EDJ-KQ27389 | Human | 2628 | Details Get a Quote |
Displaying Records 1 To 12 Of 12 Records
Frequently Asked Questions About creatine metabolic process
What is GO:0006600 creatine metabolic process?
GO:0006600 is a Gene Ontology biological process term defined as the chemical reactions and pathways involving creatine, a compound synthesized from arginine, glycine, and methionine that occurs in muscle.
What genes are involved in creatine metabolic process?
Key genes include GATM, GAMT, SLC6A8, CKB, CKM, CKMT1A, CKMT1B, and CKMT2, which mediate creatine biosynthesis, transport, and phosphorylation.
Why is creatine metabolism important for energy?
Creatine metabolism maintains ATP homeostasis through the creatine/phosphocreatine shuttle, buffering energy in tissues with high demand such as muscle and brain.
What diseases are linked to creatine metabolism defects?
Creatine deficiency syndromes (GATM, GAMT, SLC6A8 deficiencies), cancer progression, and metabolic myopathies are linked to altered creatine metabolism.
How is creatine synthesized in the body?
Creatine is synthesized in two steps: GATM in the kidney converts arginine and glycine to guanidinoacetate, which is then methylated by GAMT in the liver to form creatine.
What is the role of SLC6A8 in creatine metabolism?
SLC6A8 encodes the creatine transporter CT1, which mediates sodium- and chloride-dependent creatine uptake into cells; mutations cause creatine transporter deficiency.
Can creatine supplementation affect health beyond athletics?
Yes, creatine supplementation has shown benefits in women's health, clinical populations, and potentially in cancer therapy, though more research is needed.
How can CRISPR be used to study creatine metabolism?
CRISPR knockout, point mutation, knock-in, and overexpression models enable functional studies of creatine metabolism genes in health and disease.
What methods are used to measure creatine metabolism?
Stable isotope tracing, mass spectrometry, RNA-seq, MRS, and biosensors are commonly used to measure creatine synthesis, transport, and energy flux.
Is creatine metabolism involved in cancer?
Yes, hypoxia-induced creatine uptake via SLC6A8 can reprogram metabolism and antagonize PARP1-mediated cell death in hepatocellular carcinoma, promoting tumor progression.
Conclusion
GO:0006600 creatine metabolic process is a fundamental biological pathway that integrates energy homeostasis, biosynthesis, transport, and systemic metabolic regulation. Its roles in health and disease, from creatine deficiency syndromes to cancer, make it a compelling target for basic and translational research. Advances in CRISPR-based models and metabolic profiling continue to unravel the complexities of this pathway, offering new opportunities for therapeutic intervention.
References
- 1. Smith-Ryan AE et al.. 2021. Creatine Supplementation in Women's Health: A Lifespan Perspective.. Nutrients 13(3) PMID: 33800439
- 2. Smith-Ryan AE et al.. 2025. Creatine in women's health: bridging the gap from menstruation through pregnancy to menopause.. J Int Soc Sports Nutr 22(1):2502094 PMID: 40371844
- 3. Gutiérrez-Hellín J et al.. 2024. Creatine Supplementation Beyond Athletics: Benefits of Different Types of Creatine for Women, Vegans, and Clinical Populations-A Narrative Review.. Nutrients 17(1) PMID: 39796530
- 4. Kreider RB et al.. 2021. Creatine in Health and Disease.. Nutrients 13(2) PMID: 33572884
- 5. Bonilla DA et al.. 2021. Metabolic Basis of Creatine in Health and Disease: A Bioinformatics-Assisted Review.. Nutrients 13(4) PMID: 33918657
- 6. Li RZ et al.. 2025. Hypoxia-Induced Creatine Uptake Reprograms Metabolism to Antagonize PARP1-Mediated Cell Death and Facilitate Tumor Progression in Hepatocellular Carcinoma.. Cancer Res 85(19):3671-3688 PMID: 40742312
- 7. Kazak L et al.. 2020. Creatine metabolism: energy homeostasis, immunity and cancer biology.. Nat Rev Endocrinol 16(8):421-436 PMID: 32493980
- 8. Su Y. 2025. Three-dimensional network of creatine metabolism: From intracellular energy shuttle to systemic metabolic regulatory switch.. Mol Metab 100:102228 PMID: 40780445
